课题基金 / 基金详情

Clinical Core

Clinical Core
临床核心
批准号:
10264662
负责人:
John M Olichney
金额:
$109.68万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-15 至 2026-06-30
关键词:
AffectAfrican AmericanAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaAsiansAssessment toolAutopsyAwarenessBehavioralBiologicalBiological MarkersBloodBrainBrain imagingCaringCessation of lifeClassificationClinicalClinical DataCognitionCognitiveCognitive agingCollaborationsCollectionCommunitiesComplexConsentDNADataData CollectionDatabasesDementiaDevelopmentDiagnosisDiagnosticDiseaseEducationElderlyEnrollmentEpidemiologyExposure toFamilyGoalsHeterogeneityHispanicsImageImmigrationImpaired cognitionImpairmentIndividualInterdisciplinary StudyIntervention TrialLanguageLatinxLeadershipLongitudinal cohortMagnetic Resonance ImagingMeasurementMethodsMissionPathologyPhenotypePlasmaPopulationPopulation HeterogeneityPopulation StudyPositron-Emission TomographyPrevalencePreventionProtocols documentationPsychometricsPublic HealthRNAResearchResearch MethodologyResearch PersonnelResourcesRetrievalRisk FactorsSamplingScienceSpecimenStandardizationTrainingTranslatingTranslational ResearchUnderrepresented PopulationsVascular DiseasesWorkaging brainbiomarker developmentbrain healthbrain researchclinical Diagnosisclinical diagnosticscohortdaily functioningeffective therapyepidemiology studyexperiencefollow-upinnovationmodifiable riskmultidisciplinarymultiple data sourcesneuroimagingnoveloutcome predictionpatient engagementprotective factorsracial and ethnic disparitiesrecruitsocialsocial culturesocioeconomicssuccesstoolunderserved communityvascular contributionsvascular risk factor

项目摘要

项目成果

John M Olichney的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY - Clinical Core (CC) The mission of the UC Davis Alzheimer’s Disease Research Center (UCD ADRC) is to advance the science of healthy brain aging among diverse populations while caring for those affected by dementia. This mission and the work of the Clinical Core (CC) contribute to many of the milestones and goals set forth by the National Alzheimer’s Disease Plan (NAPA). The CC is essential to the UCD ADRC’s mission, in part, by maintaining the Longitudinal Diversity Cohort (LDC), a large, highly diverse group of older adults followed annually through autopsy, and by overseeing the collection of the multiple sources of data obtained from these individuals. This cohort is highly unique among ADRCs in that it includes substantial numbers of older adults from two of the largest underrepresented groups in the U.S.: African Americans (~25% of the cohort) and Hispanics (~25%). This diversity translates into heterogeneity of cognitive trajectories, incident Alzheimer’s disease and related dementias (ADRD), risk factors and lifecourse experiences, and the prevalence of vascular risk factors consistent with community populations, thereby providing a valuable resource for studying both AD and mixed pathologies. The sample is similarly diverse in terms of education (range of 0-20 years), native language, socioeconomic and immigration status, and exposure to adversity. Through primarily community recruitment, the UCD ADRC enrolls cognitively normal and mildly impaired individuals to study cognitive decline and the transition to various stages of disease. This facilitates identification of novel modifiable risk and protective factors and biomarker development, both of which have implications for dementia prevention. All individuals in the LDC are characterized at an uncommonly rich level (well beyond the UDS) that includes neuroimaging and blood biomarkers, annual diagnostic classification, psychometrically rigorous measurement of cognition and daily function (separate from measurements used for diagnosis) and extensive collection of lifecourse sociocultural and behavioral data. The LDC is a well established cohort with extensive data from both active (n=425) and inactive cases (n>950), some with 15+ years of follow-up. All of this data has been integrated into the UCD ADRC database that provides an easily accessible research resource widely utilized by researchers both within and outside of our Center. Data from the LDC has contributed to innovative new research findings in many areas including enhancing our understanding of ethnic/racial disparities in cognitive aging and the contributions of vascular disease to brain health, among many other contributions. In addition, the CC has the added advantage of creating bi-directional translational relationships with epidemiological studies aimed at understanding the complex determinants of ADRD and accelerating the development of effective treatment and prevention across the ADRD spectrum.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
  • 批准号:
    10461122
  • 项目类别:
  • 资助金额:
    $111.42万
  • 财政年份:
    2021
  • 负责人:
    John M Olichney
  • 依托单位:
Clinical Core
  • 批准号:
    10666434
  • 项目类别:
  • 资助金额:
    $111.77万
  • 财政年份:
    2021
  • 负责人:
    John M Olichney
  • 依托单位:
Phase II RCT of High-dose Vitamin D Supplements in Older Adults without Dementia
Phase II RCT of High-dose Vitamin D Supplements in Older Adults without Dementia
海外基金